The past three decades have borne witness to many advances in the understanding of the
molecular biology and treatment of nasopharyngeal carcinoma (NPC), an Epstein–Barr virus (…

Nasopharyngeal carcinoma of the undifferentiated subtype is endemic to southern China,
and patient prognosis has improved significantly over the past three decades because of …

BACKGROUND Recent advances in the treatment of nasopharyngeal carcinoma (NPC) have
transpired into better treatment outcomes for patients with locoregionally advanced NPC, …

This phase III randomized study compared concurrent cisplatin–radiotherapy (CRT) versus
radiotherapy (RT) alone in patients with locoregionally advanced nasopharyngeal carcinoma…

Background Circulating cell-free Epstein–Barr virus (EBV) DNA is a biomarker for nasopharyngeal
carcinoma. We conducted a prospective study to investigate whether EBV DNA in …

Background: Epstein-Barr virus (EBV) DNA can be detected and quantified in the plasma of
patients with EBV-related tumors, such as nasopharyngeal carcinoma (NPC). Although NPC …

We explored the detection of genome-wide hypomethylation in plasma using shotgun
massively parallel bisulfite sequencing as a marker for cancer. Tumor-associated copy number …

Purpose To evaluate efficacy and toxicity of cetuximab plus carboplatin in recurrent or
metastatic nasopharyngeal carcinoma (NPC) resistant to platinum treatment. Patients and …

… Collection and assembly of data: Brigette BY Ma, Wan-Teck Lim, Boon-Cher Goh, Edwin
P. Hui, Kwok-Wai Lo, Adam Pettinger, Nathan R. Foster, Jonathan W. … Brigette BY Ma …

Nasopharyngeal carcinoma (NPC) is an aggressive head and neck cancer characterized by
Epstein-Barr virus (EBV) infection and dense lymphocyte infiltration. The scarcity of NPC …